1. MARKETS
  2. SECTOR : BANKING & FINANCE
  3. INDUSTRY : FINANCIAL CONGLOMERATES
  4. BRIDGEBIO ONCOLOGY THERAPEUTICS INC.
BridgeBio Oncology Therapeutics Inc. XNAS: BBOT
9.73 -0.66 (-6.35%)
182.7K
XNAS Volume

XNAS 15 Sep, 2025 5:30 PM (EDT)



Insider Trading disclosures for BridgeBio Oncology Therapeutics Inc.

The latest disclosure was made by Frank P. McCormick in BridgeBio Oncology Therapeutics Inc. where a trade of 91,076 Stock Option (Right to Buy) done was reported to US exchanges on Aug. 26, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Frank P. McCormick Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Aug 2025 91,076 91,076 - - Stock Option (Right to Buy)
Pedro J. Beltran Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Aug 2025 357,177 357,177 - - Stock Option (Right to Buy)
Jacob Bauer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Aug 2025 138,193 138,193 - - Stock Option (Right to Buy)
Eli M. Wallace Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Aug 2025 499,731 499,731 - - Stock Option (Right to Buy)
Yong Ben Chief Med & Dev Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Aug 2025 357,177 357,177 - - Stock Option (Right to Buy)
Bihua Chen Director, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Aug 2025 4,172,126 4,681,126 - - Common Stock
Bihua Chen Director, Ten Percent Owner Sale or transfer of securities back to the company at price $ 0.00 per share. 11 Aug 2025 152,940 4,528,186 - 0 Common Stock
Bihua Chen Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 10.72 per share. 11 Aug 2025 760,496 2,187,536 - 10.7 8,150,464 Common Stock
Bihua Chen Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 10.72 per share. 11 Aug 2025 639,110 1,542,710 - 10.7 6,849,534 Common Stock
Bihua Chen Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 10.72 per share. 11 Aug 2025 5,598,425 5,667,785 - 10.7 60,000,000 Common Stock
Bihua Chen Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Aug 2025 1,905,046 1,905,046 - - Common Stock
Bihua Chen Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Aug 2025 1,762,760 3,305,470 - - Common Stock
Bihua Chen Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Aug 2025 284,571 5,952,356 - - Common Stock
Bihua Chen Director, Ten Percent Owner Sale or transfer of securities back to the company at price $ 0.00 per share. 11 Aug 2025 307,874 4,172,126 - - Class B ordinary shares
Bihua Chen Director, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Aug 2025 4,172,126 0 - - Class B ordinary shares
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures